Nyxoah SA Files September 2025 6-K Report
Ticker: NYXH · Form: 6-K · Filed: Sep 15, 2025 · CIK: 1857190
| Field | Detail |
|---|---|
| Company | Nyxoah SA (NYXH) |
| Form Type | 6-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, reporting
TL;DR
Nyxoah SA filed its monthly 6-K report on 9/15/25, standard procedure for foreign issuers.
AI Summary
Nyxoah SA, a medical device company, filed a Form 6-K on September 15, 2025. This report is for the month of September 2025 and is filed under the Securities Exchange Act of 1934. The company is based in Mont-Saint-Guibert, Belgium.
Why It Matters
This filing indicates ongoing reporting requirements for Nyxoah SA, a publicly traded company, providing updates to investors and the market.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer information and does not contain significant new financial or operational disclosures.
Key Players & Entities
- Nyxoah SA (company) — Registrant
- 001-40552 (company) — Commission File Number
- September 2025 (date) — Reporting Period
- 1934 Act (company) — Securities Exchange Act
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (company) — Principal Executive Office Address
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the filer?
The filer is Nyxoah SA.
What is the reporting period for this Form 6-K?
The report is for the month of September 2025.
What is the company's principal executive office address?
The principal executive office is located at Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium.
What is the Commission File Number for Nyxoah SA?
The Commission File Number is 001-40552.
Filing Stats: 616 words · 2 min read · ~2 pages · Grade level 16.2 · Accepted 2025-09-15 16:19:07
Filing Documents
- tm2526060d1_6k.htm (6-K) — 13KB
- tm2526060d1_ex99-1.htm (EX-99.1) — 10KB
- tm2526060d1_ex99-1img01.jpg (GRAPHIC) — 4KB
- 0001104659-25-090018.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NYXOAH SA Date: September 15, 2025 By: /s/ John Landry Name: John Landry Title: Chief Financial Officer 4